VALN
#2829
Valneva SE - American Depositary Shares
5.9 3 USD
+0.03%
Market Price
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
Intervallo Annuale
Variazione giornaliera
+2.60%
Variazione Mensile
-12.28%
Variazione di 6 mesi
-5.27%
Variazione Annuale
-41.92%
Chiusura Precedente
5.7 8
Open
5.8 6
Minimo
5.8 5
Massimo
5.9 6
Financials
- Market Capitalization 514.55 M
- Employee 674
- Founded 2013
- CEO Thomas Lingelbach
- Website www.valneva.com
- Headquarter France
- FIGI BBG00ZZPBH08
- Industry Biotecnologia
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 2815 |  MNPR Monopar Therapeutics Inc. - Common Stock | 77.05 USD | -2.42% | -0.03% | -31.20% | +41.07% | 517.17 M USD | ||
| 2818 |  CTMX CytomX Therapeutics, Inc. - Common Stock | 2.42 USD | -5.84% | -6.56% | -26.67% | -27.76% | 527.32 M USD | ||
| 2830 |  RGNX REGENXBIO Inc. - Common Stock | 7.77 USD | -3.72% | -0.26% | -9.44% | -42.14% | 512.92 M USD | ||
| 2836 |  PROK ProKidney Corp. - Class A Ordinary Shares | 1.67 USD | -4.02% | +5.70% | -7.22% | -19.71% | 504.88 M USD |